MASCT by Hengrui Yuanzheng Biotechnology for Metastatic Colorectal Cancer: Likelihood of Approval

MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Metastatic Colorectal Cancer.

Does internet use boost psychological well-being?

Study published in Technology, Mind, and Behavior found that internet access and use significantly predict higher psychological well-being, with over 96% of cases showing improved

May 16, 2024

Screen-and-Treat for Bacterial Vaginosis Fails to Reduce Preterm Births

Molecular screening for and treatment of bacterial vaginosis (BV) did not significantly reduce preterm birth rates compared with usual care, according to the randomized AuTop

July 18, 2023

Drug Companies, Allies Fight Back on Medicare Drug Price Negotiations

Experts debated the claims made by drug companies and industry allies suing the federal government over its recently launched drug price negotiation program during an

September 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.